Risk factors for recurrent primary sclerosing cholangitis after liver transplantation

Journal of Hepatology

Volumn 63, Issue 5, 2015, Pages 1139-1146

  Ravikumar, Reena ^a   Tsochatzis, Emmanuel ^a   Jose, Sophie ^b   Allison, Michael ^c   Athale, Anuja ^d   Creamer, Felicity ^e   Gunson, Bridget ^f   Iyer, Vikram ^f   Madanur, Mansoor ^d   Manas, Derek ^g   Monaco, Andrea ^a   Mirza, Darius ^f   Owen, Nicola ^c   Roberts, Keith ^f   Sen, Gourab ^g   Srinivasan, Parthi ^d   Wigmore, Stephen ^g   Fusai, Giuseppe ^a   Fernando, Bimbi ^a   Burroughs, Andrew ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

^e ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^f UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^g FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Colectomy; Liver transplantation; Patients and graft survival; Recurrent PSC; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; COLON RESECTION; CROHN DISEASE; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENT DISEASE; RISK FACTOR; ULCERATIVE COLITIS; UNITED KINGDOM; ADVERSE EFFECTS; CHOLANGITIS, SCLEROSING; CLINICAL TRIAL; FOLLOW UP; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TRENDS;

ADULT; CHOLANGITIS, SCLEROSING; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; UNITED KINGDOM;

EID: 84945477969     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.07.005     Document Type: Article

References (29)

1. N.F. LaRusso, B.L. Shneider, D. Black, G.J. Gores, S.P. James, E. Doo, and et al. Primary sclerosing cholangitis: summary of a workshop Hepatology 44 2006 746 764
2. D.S. Kotlyar, M.S. Campbell, and K.R. Reddy Recurrence of diseases following orthotopic liver transplantation Am J Gastroenterol 101 2006 1370 1378
3. A. Vera, S. Moledina, B. Gunson, S. Hubscher, D. Mirza, S. Olliff, and et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft Lancet 360 2002 1943 1944
4. E. Alabraba, P. Nightingale, B. Gunson, S. Hubscher, S. Olliff, D. Mirza, and et al. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts Liver Transpl 15 2009 330 340
5. E. Cholongitas, V. Shusang, G.V. Papatheodoridis, L. Marelli, P. Manousou, N. Rolando, and et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation Liver Transpl 14 2008 138 143
6. I.A. Rowe, K. Webb, B.K. Gunson, N. Mehta, S. Haque, and J. Neuberger The impact of disease recurrence on graft survival following liver transplantation: a single centre experience Transpl Int 21 2008 459 465
7. I. Dvorchik, M. Subotin, A.J. Demetris, J.J. Fung, T.E. Starzl, S. Wieand, and et al. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis Hepatology 35 2002 380 384
8. B. Brandsaeter, E. Schrumpf, O. Bentdal, K. Brabrand, H.J. Smith, A. Abildgaard, and et al. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors Liver Transpl 11 2005 1361 1369
9. D.R. Jeyarajah, G.J. Netto, S.P. Lee, G. Testa, O. Abbasoglu, B.S. Husberg, and et al. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation 66 1998 1300 1306
10. R.M. Soetikno, O.S. Lin, P.A. Heidenreich, H.S. Young, and M.O. Blackstone Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis Gastrointest Endosc 56 2002 48 54
11. E.V. Loftus Jr., G.C. Harewood, C.G. Loftus, W.J. Tremaine, W.S. Harmsen, A.R. Zinsmeister, and et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis Gut 54 2005 91 96
12. G.V. Papatheodoridis, M. Hamilton, P.K. Mistry, B. Davidson, K. Rolles, and A.K. Burroughs Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis Gut 43 1998 639 644
13. J.R. Cangemi, R.H. Wiesner, S.J. Beaver, J. Ludwig, R.L. MacCarty, R.R. Dozois, and et al. Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis Gastroenterology 96 1989 790 794
14. I.W. Graziadei Recurrence of primary sclerosing cholangitis after liver transplantation Liver Transpl 8 2002 575 581
15. I.W. Graziadei, R.H. Wiesner, K.P. Batts, P.J. Marotta, N.F. LaRusso, M.K. Porayko, and et al. Recurrence of primary sclerosing cholangitis following liver transplantation Hepatology 29 1999 1050 1056
16. A.J. Demetris Distinguishing between recurrent primary sclerosing cholangitis and chronic rejection Liver Transpl 12 2006 S68 S72
17. R.F. Harrison, M.H. Davies, J.M. Neuberger, and S.G. Hubscher Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology 20 1994 356 361
18. M. Gautam, R. Cheruvattath, and V. Balan Recurrence of autoimmune liver disease after liver transplantation: a systematic review Liver Transpl 12 2006 1813 1824
19. I.W. Graziadei, R.H. Wiesner, P.J. Marotta, M.K. Porayko, J.E. Hay, M.R. Charlton, and et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis Hepatology 30 1999 1121 1127
20. F. Gordon Recurrent primary sclerosing cholangitis: clinical diagnosis and long-term management issues Liver Transpl 12 2006 S73 S75
21. M. Kugelmas, P. Spiegelman, M.J. Osgood, D.A. Young, J.F. Trotter, T. Steinberg, and et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation Liver Transpl 9 2003 727 732
22. L. Marelli, E. Xirouchakis, G. Kalambokis, E. Cholongitas, M.I. Hamilton, and A.K. Burroughs Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis? Gut 60 2011 1224 1228
23. U. Navaneethan, M. Choudhary, P.G. Venkatesh, B.A. Lashner, F.H. Remzi, B. Shen, and et al. The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis Aliment Pharmacol Ther 35 9 2012 1054 1063
24. K.J. Moncrief, A. Savu, M.M. Ma, V.G. Bain, W.W. Wong, and P. Tandon The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation - A single-centre experience Can J Gastroenterol 24 2010 40 46
25. A.J. Grant, P.F. Lalor, M. Salmi, S. Jalkanen, and D.H. Adams Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease Lancet 359 2002 150 157
26. B. Eksteen, A.J. Grant, A. Miles, S.M. Curbishley, P.F. Lalor, S.G. Hubscher, and et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis J Exp Med 200 2004 1511 1517
27. B. Eksteen, A.E. Miles, A.J. Grant, and D.H. Adams Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease Clin Med 4 2004 173 180
28. J. Campsen, M.A. Zimmerman, J.F. Trotter, M. Wachs, T. Bak, T. Steinberg, and et al. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course Liver Transpl 14 2008 181 185
29. A. Maheshwari, H.Y. Yoo, and P.J. Thuluvath Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC Am J Gastroenterol 99 2004 538 542